Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Comparison of Gastric Volume in I-gel and ProSeal Laryngeal Mask Airways

NCT07138092 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-08-18
Last updated
2025-08-22

Condition(s) studied

Nausea and Vomiting, PostoperativeSore-throat

Investigational drug(s) / intervention(s)

i jel LMAproseal LMA

i jel LMA: Patients will be inserted i jel laryngeal mask under general anesthesia.

proseal LMA: Patients will be inserted proseal laryngeal mask under general anesthesia.

Study summary

This study was planned to compare the gastric insufflation volume between i jel and ProSeal laryngeal mask airway (LMA) and its relationship with the oropharyngeal sealing pressure and the incidence of postoperative complications in patients undergoing urological surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
79 Years
Healthy volunteers
No
Inclusion Criteria: * Patients with an ASA (American Society of Anesthesiologists) physical status score of 1 to 3 * undergoing urological surgeries performed with I-gel or ProSeal LMA Exclusion Criteria: * Difficult airway * Clinically significant upper respiratory tract infection * Pre-existing airway disease * Pre-existing airway disease * History of head and neck surgery * Pregnant patients * Patients with upper gastrointestinal tract disease

Primary outcome measure(s)

  • Measurement of oropharyngeal leak pressure (OLP) — Five minutes after successful LMA placement
    One minute after successful LMA placement and fixation, oropharyngeal leak pressure (OLP) will be measured by setting the adjustable pressure limiting valve (APL) to 40 mmHg and maintaining a fresh gas flow of 3 L/min. The OLP will be recorded as the pressure at which an audible leak sound is heard from the mouth.

Trial sites (1)

FacilityCityRegionStatus
Zeynep Koç Yenimahalle Ankara
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07138092 on ClinicalTrials.gov ↗ ← All trials in Turkey